Allspring Global Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,574
| Closed | -$79.3K | – | 1636 |
|
|
2025
Q1 | $79.3K | Buy |
+10,574
| New | +$79.3K | ﹤0.01% | 1699 |
|
|
2024
Q4 | – | Sell |
-101
| Closed | -$767 | – | 1823 |
|
|
2024
Q3 | $767 | Buy |
+101
| New | +$767 | ﹤0.01% | 2352 |
|
|
2023
Q4 | – | Sell |
-2,478
| Closed | -$17.5K | – | 2259 |
|
|
2023
Q3 | $17.5K | Buy |
2,478
+896
| +57% | +$6.34K | ﹤0.01% | 2527 |
|
|
2023
Q2 | $11.1K | Sell |
1,582
-3,689
| -70% | -$26K | ﹤0.01% | 2521 |
|
|
2023
Q1 | $44K | Sell |
5,271
-6,298
| -54% | -$52.5K | ﹤0.01% | 2318 |
|
|
2022
Q4 | $133K | Sell |
11,569
-253
| -2% | -$2.9K | ﹤0.01% | 1957 |
|
|
2022
Q3 | $148K | Hold |
11,822
| – | – | ﹤0.01% | 1914 |
|
|
2022
Q2 | $125K | Sell |
11,822
-118,438
| -91% | -$1.25M | ﹤0.01% | 1979 |
|
|
2022
Q1 | $2.12M | Sell |
130,260
-22,983
| -15% | -$374K | ﹤0.01% | 1473 |
|
|
2021
Q4 | $2.12M | Buy |
+153,243
| New | +$2.12M | ﹤0.01% | 1508 |
|